Jump Financial’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Jump Financial’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-62,589	Closed	-$4.26M	–	2159
2022 Q3	$4.26M	Buy	62,589 +27,615	+79%	+$1.52M	0.17%	177
2022 Q2	$1.12M	Buy	+34,974	New	+$1.02M	0.05%	522
2021 Q1	–	Sell	-26,500	Closed	-$1.15M	–	1412
2020 Q4	$1.15M	Buy	+26,500	New	+$1.31M	0.2%	125

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Jump Financial's GBT Position: Q4 2022 in Review

Jump Financial sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 62,589 shares — an estimated $4.26M sold.

Jump Financial first reported a position in GBT in Q4 2020 and held it in 3 quarters. The position peaked at $4.26M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

Jump Financial reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Jump Financial sold 62,589 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $4.26M.
Jump Financial first reported a position in Global Blood Therapeutics, Inc. in Q4 2020 and held it in 3 quarters.
Jump Financial's Global Blood Therapeutics, Inc. position peaked at $4.26M in Q3 2022.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Jump Financial's 13F filing for Q4 2022, filed 14 Feb 2023.